SANUWAVE Health, Inc. Appoints Peter Sorensen as CFO
April 02, 2024 at 01:30 am IST
Share
SANUWAVE Health, Inc. announced the hiring of Peter Sorensen as its new CFO. Sorensen brings deep experience in finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human resources from his prior roles heading the finance and HR teams at Endogenex, Inc., a medical device company developing a new approach to the treatment of type 2 diabetes. Prior to working with Endogenex, Sorensen did financial planning and analysis for the Caisson Interventional and Heart Failure divisions of LivaNova PLC and did FP&A and software consulting for eCapital Advisors, a management consulting firm specializing in technology implementations to support data driven decision making. He earned his BA in business administration from Bethel University and an MBA from the Herberger Business School at St. Cloud State University in Minnesota.Sorensen begins work at SANUWAVE on April 1, 2024.
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. The Company is a provider of Food and Drug Administration (FDA)-approved wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The Company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and others. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing from within. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression (PACE) technology to converge at precise selected targets to produce an extremely short duration compression burst.